Literature DB >> 25075035

Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.

Sarah Annette Von Schulz-Hausmann1, Leonard Christopher Schmeel1, Frederic Carsten Schmeel1, Ingo G H Schmidt-Wolf2.   

Abstract

BACKGROUND/AIM: Advanced renal cancer still has a very poor prognosis. In this regard recent investigations demonstrated a constitutive activation of the Wnt signaling pathway in renal cell carcinoma (RCC) thereby promoting an exaggerated cell proliferation. Especially, β-catenin overactivation and the functional loss of endogenous Wnt antagonists are associated with RCC carcinogenesis and progression. Thus, influencing Wnt signaling might represent a promising target in RCC treatment.
MATERIALS AND METHODS: It was recently confirmed that ethacrynic acid (EA), ciclopirox olamine (CIC) and piroctone olamine (PO) can inhibit Wnt signaling in various cancer cell lines. Herein we investigated their cytotoxic potential towards human RCC cells and their influence on the Wnt pathway concerning apoptosis as determined by 3,3'-dihexyloxacarbocyanine iodide (DiOC6) and propidium iodide (PI) staining in flow cytometry and immunoblotting.
RESULTS: All three agents, EA, CIC and PO triggered a significant apoptotic activity in tested RCC cell lines in a time- and concentration-dependent manner. Moreover, exposure to CIC and PO decreased the expression of β-catenin as the pivotal feature within the canonical Wnt pathway. However, β-catenin expression increased upon the treatment with EA.
CONCLUSION: These results reveal a significant selective induction of apoptosis by EA, CIC and PO and suggest a suppression of RCC survival in part due to inhibition of Wnt/β-catenin signaling. The development of targeted-therapies affecting the Wnt signaling pathway might therefore lead to novel treatment options for RCC patients. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Renal cancer; Wnt inhibitors; Wnt pathway; beta-catenin; signaling therapies

Mesh:

Substances:

Year:  2014        PMID: 25075035

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.

Authors:  Ahmad M Al-Dali; Hans Weiher; Ingo G H Schmidt-Wolf
Journal:  Oncol Lett       Date:  2018-09-20       Impact factor: 2.967

2.  Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.

Authors:  Wenxing Fan; Jie Huang; Hua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Repositioning the Old Fungicide Ciclopirox for New Medical Uses.

Authors:  Tao Shen; Shile Huang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

4.  Astrocyte elevated gene-1 promotes the proliferation and invasion of breast cancer cells by activating the Wnt/β-catenin signaling pathway.

Authors:  Mengxi Li; Yuna Dai; Li Wang; Lei Li
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

Review 5.  Histone deacetylase 10, a potential epigenetic target for therapy.

Authors:  Fajuan Cheng; Bin Zheng; Jianwei Wang; Guiting Zhao; Zhongshun Yao; Zhihong Niu; Wei He
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 6.  Reposition of the Fungicide Ciclopirox for Cancer Treatment.

Authors:  Zhu Huang; Shile Huang
Journal:  Recent Pat Anticancer Drug Discov       Date:  2021       Impact factor: 3.038

7.  Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation via β-catenin signaling.

Authors:  Yu Liu; Liang Yang; Bo Liu; Yu-Gang Jiang
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

Review 8.  Wnt Signaling in Renal Cell Carcinoma.

Authors:  Qi Xu; Mirja Krause; Anatoly Samoylenko; Seppo Vainio
Journal:  Cancers (Basel)       Date:  2016-06-17       Impact factor: 6.639

9.  Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.

Authors:  Yicheng Chen; Qiaoli Huang; Hua Zhou; Yueping Wang; Xian Hu; Tao Li
Journal:  Oncotarget       Date:  2016-08-02

10.  MicroRNA-148b enhances proliferation and apoptosis in human renal cancer cells via directly targeting MAP3K9.

Authors:  Fang Nie; Tianming Liu; Liang Zhong; Xianggui Yang; Yunhong Liu; Hongwei Xia; Xiaoqiang Liu; Xiaoyan Wang; Zhicheng Liu; Li Zhou; Zhaomin Mao; Qin Zhou; Tingmei Chen
Journal:  Mol Med Rep       Date:  2015-11-11       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.